Treatment patterns and outcomes in elderly patients with multiple myeloma

Leukemia

Volumn 27, Issue 4, 2013, Pages 971-974

  Bang, S M ^a   Kyle, R A ^a   Rajkumar, S V ^a   Kumar, S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; PREDNISONE; THALIDOMIDE;

AGE DISTRIBUTION; AMYLOIDOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CYTOGENETICS; GERIATRICS; LETTER; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MULTIPLE MYELOMA; TREATMENT OUTCOME;

EID: 84876151912     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.259     Document Type: Letter

References (14)

1. Median age of cancer patients at diagnosis, 2003-2007 by primary cancer site, race and sex (http://seer.cancer.gov/csr/1975-2007/results-single/sect-01- table. 11-2pgs.pdf).
2. Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol 2004; 127: 299-304.
3. Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 2007; 25: 1993-1999.
4. Froom P, Quitt M, Aghai E. Multiple myeloma in the geriatric patient. Cancer 1990; 66: 965-967.
5. Bladé J, Muñoz M, Fontanillas M, San Miguel J, Alcalá A, Maldonado J et al. Treatment of multiple myeloma in elderly people: long-term results in 178 patients. Age Ageing 1996; 25: 357-361.
6. Rodon P, Linassier C, Gauvain JB, Benboubker L, Goupille P, Maigre M et al. Multiple myeloma in elderly patients: presenting features and outcome. Eur J Haematol 2001; 66: 11-17.
7. Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P et al. Multiple myeloma in elderly patients: prognostic factors and outcome. Eur J Haematol 2005; 75: 370-375.
8. Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. J Clin Oncol 2009; 27: 3664-3670.
9. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3-9.
10. Penson RT, Daniels KJ, Lynch Jr. TJ. Too old to care? Oncologist 2004; 9: 343-352.
11. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994; 86: 1766-1770.
12. Clough V, Delamore IW, Whittaker JA. Multiple myeloma in a young woman. Ann Intern Med 1977; 86: 117-118.
13. Khunger JM, Sharma M, Talib VH. Multiple myeloma presenting as primary non-secretory plasma cell leukemia. Indian J Pathol Microbiol 2003; 46: 104-105.
14. Chen CC, Gau JP, Ho CH, Lin JS, Chiou HJ, Lirng JF. Aggressive multiple myeloma with brain involvement in a young patient. J Chin Med Assoc 2003; 66: 177-180.